Anthony Gonçalvès
Impact in
- Oncology top 0.2%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 250
- Cancer Treatment and Pharmacology 80
- HER2/EGFR in Cancer Research 75
- PARP inhibition in cancer therapy 36
- Colorectal Cancer Treatments and Studies 31
- Cancer Research 103
- Breast Cancer Treatment Studies 57
- Cancer Genomics and Diagnostics 44
- Co-authors
- François BertucciPatrice ViensDaniel BirnbaumJoanne L. BlumHenri RochéSara A. HurvitzJohannes EttlJennifer K. Litton
- Journals
- Journal of Clinical Oncology (43 papers)Annals of Oncology (33 papers)Cancer Research (25 papers)Cancers (14 papers)European Journal of Cancer (13 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Anthony Gonçalvès
303 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 6.2k
- Cancer Research 2.3k
- Pulmonary and Respiratory Medicine 3.0k
- Immunology 1.4k
- Genetics 572
Countries citing papers authored by Anthony Gonçalvès
This map shows the geographic impact of Anthony Gonçalvès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Gonçalvès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Gonçalvès more than expected).
Fields of papers citing papers by Anthony Gonçalvès
This network shows the impact of papers produced by Anthony Gonçalvès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Gonçalvès. The network helps show where Anthony Gonçalvès may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Gonçalvès, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 28 | |
| 6 | 2022 | 20 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 126 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 28 | |
| 14 | 2019 | 9 | |
| 15 | 2018 | 19 | |
| 16 | Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation Hit paper breakdown → | 2018 | 1401 |
| 17 | 2018 | 40 | |
| 18 | 2018 | 38 | |
| 19 | 2015 | 16 | |
| 20 | A phase 1b study of Trebananib plus Paclitaxel and Trastuzumab or Capecitabine and Lapatinib in patients with HER2+ locally recurrent or metastatic breast cancer | 2015 | 1 |
About Anthony Gonçalvès
Anthony Gonçalvès is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 318 papers that have together received 9.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (80 papers), Cancer Treatment and Pharmacology (80 papers), HER2/EGFR in Cancer Research (75 papers), Breast Cancer Treatment Studies (57 papers), Cancer Genomics and Diagnostics (44 papers), PARP inhibition in cancer therapy (36 papers), BRCA gene mutations in cancer (31 papers) and Colorectal Cancer Treatments and Studies (31 papers). The work is most often cited by research in Oncology (6.2k citations), Cancer Research (2.3k citations), Pulmonary and Respiratory Medicine (3.0k citations), Immunology (1.4k citations) and Genetics (572 citations). Anthony Gonçalvès has collaborated with scholars based in France, United States and Spain. Frequent co-authors include François Bertucci, Patrice Viens, Daniel Birnbaum, Joanne L. Blum, Henri Roché, Sara A. Hurvitz, Johannes Ettl, Jennifer K. Litton, Hope S. Rugo and Ruben G.W. Quek. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancers and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.